NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 46 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,641,006 | -10.1% | 18,003 | -10.0% | 0.18% | -21.6% |
Q2 2023 | $17,403,158 | +4.0% | 20,003 | +3.9% | 0.23% | 0.0% |
Q1 2023 | $16,741,171 | -32.4% | 19,254 | -99.9% | 0.23% | -40.1% |
Q4 2022 | $24,768,955 | +4.2% | 27,771,000 | -47.1% | 0.39% | +43.9% |
Q3 2022 | $23,772,749 | +89.4% | 52,542,000 | +362258.6% | 0.27% | +8.5% |
Q2 2022 | $12,550,000 | -66.8% | 14,500 | -100.0% | 0.25% | -45.4% |
Q1 2022 | $37,762,000 | +22.7% | 41,383,000 | +23.6% | 0.45% | +104.5% |
Q4 2021 | $30,766,000 | – | 33,485,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 60,500,000 | $55,131,000 | 3.79% |
Ayrton Capital LLC | 1,500,000 | $1,367,000 | 1.78% |
DeepCurrents Investment Group LLC | 58,391,000 | $53,156,000 | 1.66% |
ABSOLUTE INVESTMENT ADVISERS, LLC | 6,000,000 | $5,460,000 | 1.22% |
Context Capital Management, LLC | 12,900 | $11,757,000 | 0.76% |
WOLVERINE ASSET MANAGEMENT LLC | 74,842,000 | $68,091,000 | 0.66% |
Verition Fund Management LLC | 41,383,000 | $37,762,000 | 0.45% |
CSS LLC/IL | 13,560,000 | $12,426,000 | 0.45% |
Aequim Alternative Investments LP | 18,000,000 | $16,425,000 | 0.43% |
Empyrean Capital Partners, LP | 10,000,000 | $9,125,000 | 0.20% |